Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 20/20 | 0.58 |
| ▸ | SLC5A1 | P13866 | 14/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | SLC5A11 | Q8WWX8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1551453 | 1.00 | SLC5A2 (0.58) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL3798505 | 1.00 | SLC5A2 (0.58) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL13083163 | 1.00 | SLC5A2 (0.58) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL18466486 | 0.95 | SLC5A2 (0.53) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL15680698 | 0.94 | SLC5A2 (0.52) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL15680868 | 0.92 | SLC5A2 (0.50) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL3684426 | 0.90 | SLC5A2 (0.47) | SLC5A2SLC5A1 | |
| SCHEMBL3680743 | 0.90 | SLC5A2 (0.47) | SLC5A2SLC5A1 | |
| SCHEMBL15680703 | 0.90 | SLC5A2 (0.51) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL15680798 | 0.89 | SLC5A2 (0.50) | SLC5A2SLC5A1ADRA2ASLC5A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2312944-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | Theracos, Inc. (US) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010009243-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | THERACOS, INC. (US) | 2010-01-21 | — | — | WO | disclosed |